Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M49,353Revenue $M6,300Net Margin (%)15.6Z-Score9.6
Enterprise Value $M47,899EPS $3.3Operating Margin %28.7F-Score8
P/E(ttm))40.4Cash Flow Per Share $4.6Pre-tax Margin (%)27.5Higher ROA y-yY
Price/Book7.410-y EBITDA Growth Rate %15.5Quick Ratio4.1Cash flow > EarningsY
Price/Sales7.75-y EBITDA Growth Rate %27.6Current Ratio4.4Lower Leverage y-yY
Price/Cash Flow20.1y-y EBITDA Growth Rate %10.5ROA % (ttm)9.3Higher Current Ratio y-yY
Dividend Yield %0.1Insider Buy (3m)0ROE % (ttm)15.2Less Shares Outstanding y-yN
Payout Ratio %5.0Shares Outstanding M298ROI % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNGeorge Soros 2014-03-31 Sold Out -0.09%$110.28 - $131.43
($121.38)
$ 165.8637%Sold Out0
AGNJoel Greenblatt 2014-03-31 Reduce-0.04%$110.28 - $131.43
($121.38)
$ 165.8637%Reduce -46%18,843
AGNRay Dalio 2014-03-31 Reduce-0.02%$110.28 - $131.43
($121.38)
$ 165.8637%Reduce -54.57%18,499
AGNFrank Sands 2013-12-31 Sold Out -1.9%$88.48 - $110.85
($95.35)
$ 165.8674%Sold Out0
AGNRay Dalio 2013-12-31 Reduce-0.14%$88.48 - $110.85
($95.35)
$ 165.8674%Reduce -81.99%40,719
AGNJoel Greenblatt 2013-12-31 Reduce-0.09%$88.48 - $110.85
($95.35)
$ 165.8674%Reduce -45.01%34,897
AGNJoel Greenblatt 2013-09-30 Add0.1%$84.24 - $92.63
($89.85)
$ 165.8685%Add 113.74%63,459
AGNGeorge Soros 2013-09-30 Buy 0.07%$84.24 - $92.63
($89.85)
$ 165.8685%New holding, 75000 sh.75,000
AGNFrank Sands 2013-09-30 Reduce-0.61%$84.24 - $92.63
($89.85)
$ 165.8685%Reduce -22.67%7,422,715
AGNRay Dalio 2013-06-30 Add0.17%$81.99 - $116.17
($103.71)
$ 165.8660%Add 2759.74%249,341
AGNJoel Greenblatt 2013-06-30 Add0.1%$81.99 - $116.17
($103.71)
$ 165.8660%Add 722.89%29,690
AGNFrank Sands 2013-06-30 Reduce-1.27%$81.99 - $116.17
($103.71)
$ 165.8660%Reduce -24.86%9,598,964
AGNFrank Sands 2013-03-31 Add0.35%$91.73 - $111.89
($106.54)
$ 165.8656%Add 7.38%12,774,895
AGNRay Dalio 2013-03-31 Reduce-0.12%$91.73 - $111.89
($106.54)
$ 165.8656%Reduce -93.77%8,719
AGNJoel Greenblatt 2013-03-31 Reduce-0.08%$91.73 - $111.89
($106.54)
$ 165.8656%Reduce -81.38%3,608
AGNFrank Sands 2012-12-31 Add0.72%$87.95 - $95.26
($91.85)
$ 165.8681%Add 19.46%11,896,641
AGNJoel Greenblatt 2012-12-31 Buy 0.1%$87.95 - $95.26
($91.85)
$ 165.8681%New holding, 19377 sh.19,377
AGNFrank Sands 2012-09-30 Add1.05%$82.08 - $95.65
($88.04)
$ 165.8688%Add 38.36%9,958,329
AGNFrank Sands 2012-06-30 Add0.16%$88.37 - $96.85
($92.45)
$ 165.8679%Add 5.73%7,197,399
AGNRay Dalio 2012-06-30 Add0.16%$88.37 - $96.85
($92.45)
$ 165.8679%Add 368.65%144,804
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AGN Dodge & Cox 2014-03-313,56400
AGN Mario Gabelli 2014-03-31126,9240.040.09-0.66%
AGN Joel Greenblatt 2014-03-3118,8430.010.04-46%
AGN Ray Dalio 2014-03-3118,4990.010.02-54.57%
AGN George Soros 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8210.49view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.736.97view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.7936.87view
HUDSON DAWN EDirector 2014-02-19Sell4,200$126.3536.26view
Diradoorian Raymond HEVPGlobal Technical Operations 2014-02-19Sell23,000$126.6635.93view
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFO 2014-02-19Sell38,900$126.3936.22view
Sherman Scott DExecutive Vice President, HR 2014-02-18Sell5,001$125.7436.93view
INGRAM DOUGLAS SPresident 2014-02-14Sell84,000$124.438.4view
PYOTT DAVID E IChairman of the Board and CEO 2014-02-12Sell252,000$123.1239.84view
BARLOW JAMES FSR. VP, Corp. Controller (PAO) 2014-02-12Sell23,875$123.5239.39view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
George Soros Reveals His Largest Stake Jul 23 2014 
Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal Apr 25 2014 
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen Apr 23 2014 
Bill Ackman Presentation - Perspective from Allergan's Largest Shareholder Apr 23 2014 
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 
Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 
Stock with High Forward Rate of Return, Donald Yacktman’s Measure Dec 26 2013 
Insiders Are Buying Ophthotech Oct 08 2013 
Sands Capital Management Update, Sells AAPL, Cuts GOOG and Others Sep 01 2013 


More From Other Websites
[$$] Allergan Defends Bylaws Amid Effort to Ward Off Valeant Jul 30 2014
Today's Momo Momentum Stock To Watch: Allergan (AGN) Jul 30 2014
Asanko Gold Announces Positive Metallurgical Results from Dynamite Hill Jul 29 2014
Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives... Jul 25 2014
Allergan gets EU recommendation on new use of eye drug Jul 25 2014
Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives... Jul 25 2014
Botox Maker’s Bosses Put Money Where Their Mouths Are Jul 24 2014
If Valeant Buys Allergan, Many Docs Will Shift Business, a Survey Finds Jul 24 2014
Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams Jul 24 2014
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
Valeant files official complaint about Allergan with Canadian regulator Jul 24 2014
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
Is Allergan (AGN) Stock a Solid Choice Right Now? Jul 24 2014
GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Jul 24 2014
Republican lawmaker to grill U.S. SEC over Ackman tactics Jul 23 2014
Correction: Blog points out Valeant's diverse portfolio is key to its success Jul 23 2014
Ominous Signs For Valeant In The Allergan Q2 Earnings Call Jul 23 2014
ALLERGAN INC Files SEC form 8-K, Other Events Jul 23 2014
[$$] Allergan Leaves Investors Smiling Jul 23 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide